Back to Search Start Over

TRPV6 modulates proliferation of human pancreatic neuroendocrine BON-1 tumour cells.

Authors :
Skrzypski M
KoƂodziejski PA
Mergler S
Khajavi N
Nowak KW
Strowski MZ
Source :
Bioscience reports [Biosci Rep] 2016 Aug 24; Vol. 36 (4). Date of Electronic Publication: 2016 Aug 24 (Print Publication: 2016).
Publication Year :
2016

Abstract

Highly Ca(2+) permeable receptor potential channel vanilloid type 6 (TRPV6) modulates a variety of biological functions including calcium-dependent cell growth and apoptosis. So far, the role of TRPV6 in controlling growth of pancreatic neuroendocrine tumour (NET) cells is unknown. In the present study, we characterize the expression of TRPV6 in pancreatic BON-1 and QGP-1 NET cells. Furthermore, we evaluate the impact of TRPV6 on intracellular calcium, the activity of nuclear factor of activated T-cells (NFAT) and proliferation of BON-1 cells. TRPV6 expression was assessed by real-time PCR and Western blot. TRPV6 mRNA expression and protein production were down-regulated by siRNA. Changes in intracellular calcium levels were detected by fluorescence calcium imaging (fura-2/AM). NFAT activity was studied by NFAT reporter assay; cell proliferation by bromodeoxyuridine (BrdU), MTT and propidium iodine staining. TRPV6 mRNA and protein are present in BON-1 and QGP-1 NET-cells. Down-regulation of TRPV6 attenuates BON-1 cell proliferation. TRPV6 down-regulation is associated with decreased Ca(2+) response pattern and reduced NFAT activity. In conclusion, TRPV6 is expressed in pancreatic NETs and modulates cell proliferation via Ca(2+)-dependent mechanism, which is accompanied by NFAT activation.<br /> (© 2016 The Author(s).)

Details

Language :
English
ISSN :
1573-4935
Volume :
36
Issue :
4
Database :
MEDLINE
Journal :
Bioscience reports
Publication Type :
Academic Journal
Accession number :
27450545
Full Text :
https://doi.org/10.1042/BSR20160106